161 related articles for article (PubMed ID: 26424557)
1. Kaiso represses the expression of glucocorticoid receptor via a methylation-dependent mechanism and attenuates the anti-apoptotic activity of glucocorticoids in breast cancer cells.
Zhou L; Zhong Y; Yang FH; Li ZB; Zhou J; Liu XH; Li M; Hu F
BMB Rep; 2016 Mar; 49(3):167-72. PubMed ID: 26424557
[TBL] [Abstract][Full Text] [Related]
2. Loss of glucocorticoid receptor expression by DNA methylation prevents glucocorticoid induced apoptosis in human small cell lung cancer cells.
Kay P; Schlossmacher G; Matthews L; Sommer P; Singh D; White A; Ray D
PLoS One; 2011; 6(10):e24839. PubMed ID: 21984896
[TBL] [Abstract][Full Text] [Related]
3. Kaiso represses the cell cycle gene cyclin D1 via sequence-specific and methyl-CpG-dependent mechanisms.
Donaldson NS; Pierre CC; Anstey MI; Robinson SC; Weerawardane SM; Daniel JM
PLoS One; 2012; 7(11):e50398. PubMed ID: 23226276
[TBL] [Abstract][Full Text] [Related]
4. The p120(ctn)-binding partner Kaiso is a bi-modal DNA-binding protein that recognizes both a sequence-specific consensus and methylated CpG dinucleotides.
Daniel JM; Spring CM; Crawford HC; Reynolds AB; Baig A
Nucleic Acids Res; 2002 Jul; 30(13):2911-9. PubMed ID: 12087177
[TBL] [Abstract][Full Text] [Related]
5. Kaiso regulates Znf131-mediated transcriptional activation.
Donaldson NS; Nordgaard CL; Pierre CC; Kelly KF; Robinson SC; Swystun L; Henriquez R; Graham M; Daniel JM
Exp Cell Res; 2010 Jun; 316(10):1692-705. PubMed ID: 20303951
[TBL] [Abstract][Full Text] [Related]
6. The glucocorticoid receptor interferes with progesterone receptor-dependent genomic regulation in breast cancer cells.
Ogara MF; Rodríguez-Seguí SA; Marini M; Nacht AS; Stortz M; Levi V; Presman DM; Vicent GP; Pecci A
Nucleic Acids Res; 2019 Nov; 47(20):10645-10661. PubMed ID: 31598691
[TBL] [Abstract][Full Text] [Related]
7. Kaiso, a transcriptional repressor, promotes cell migration and invasion of prostate cancer cells through regulation of miR-31 expression.
Wang H; Liu W; Black S; Turner O; Daniel JM; Dean-Colomb W; He QP; Davis M; Yates C
Oncotarget; 2016 Feb; 7(5):5677-89. PubMed ID: 26734997
[TBL] [Abstract][Full Text] [Related]
8. Suppression of Nuclear Factor-κB by Glucocorticoid Receptor Blocks Estrogen-Induced Apoptosis in Estrogen-Deprived Breast Cancer Cells.
Fan P; Siwak DR; Abderrahman B; Agboke FA; Yerrum S; Jordan VC
Mol Cancer Ther; 2019 Oct; 18(10):1684-1695. PubMed ID: 31511352
[TBL] [Abstract][Full Text] [Related]
9. Region-specific glucocorticoid receptor promoter methylation has both positive and negative prognostic value in patients with estrogen receptor-positive breast cancer.
Snider H; Villavarajan B; Peng Y; Shepherd LE; Robinson AC; Mueller CR
Clin Epigenetics; 2019 Nov; 11(1):155. PubMed ID: 31675993
[TBL] [Abstract][Full Text] [Related]
10. Glucocorticoid Receptor Signaling Activates TEAD4 to Promote Breast Cancer Progression.
He L; Yuan L; Sun Y; Wang P; Zhang H; Feng X; Wang Z; Zhang W; Yang C; Zeng YA; Zhao Y; Chen C; Zhang L
Cancer Res; 2019 Sep; 79(17):4399-4411. PubMed ID: 31289134
[TBL] [Abstract][Full Text] [Related]
11. Reciprocal regulation of a glucocorticoid receptor-steroidogenic factor-1 transcription complex on the Dax-1 promoter by glucocorticoids and adrenocorticotropic hormone in the adrenal cortex.
Gummow BM; Scheys JO; Cancelli VR; Hammer GD
Mol Endocrinol; 2006 Nov; 20(11):2711-23. PubMed ID: 16857744
[TBL] [Abstract][Full Text] [Related]
12. Repression of the human glycoprotein hormone alpha-subunit gene by glucocorticoids: evidence for receptor interactions with limiting transcriptional activators.
Chatterjee VK; Madison LD; Mayo S; Jameson JL
Mol Endocrinol; 1991 Jan; 5(1):100-10. PubMed ID: 1708098
[TBL] [Abstract][Full Text] [Related]
13. The Antiasthma Medication Ciclesonide Suppresses Breast Cancer Stem Cells through Inhibition of the Glucocorticoid Receptor Signaling-Dependent YAP Pathway.
Kim SL; Choi HS; Kim JH; Lee DS
Molecules; 2020 Dec; 25(24):. PubMed ID: 33352739
[TBL] [Abstract][Full Text] [Related]
14. N-CoR mediates DNA methylation-dependent repression through a methyl CpG binding protein Kaiso.
Yoon HG; Chan DW; Reynolds AB; Qin J; Wong J
Mol Cell; 2003 Sep; 12(3):723-34. PubMed ID: 14527417
[TBL] [Abstract][Full Text] [Related]
15. Expression microarray identifies the unliganded glucocorticoid receptor as a regulator of gene expression in mammary epithelial cells.
Ritter HD; Mueller CR
BMC Cancer; 2014 Apr; 14():275. PubMed ID: 24755251
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of glucocorticoid receptor in human breast tissues and related neoplasms.
Lien HC; Lu YS; Cheng AL; Chang WC; Jeng YM; Kuo YH; Huang CS; Chang KJ; Yao YT
J Pathol; 2006 Jul; 209(3):317-27. PubMed ID: 16639692
[TBL] [Abstract][Full Text] [Related]
17. Antitumoral actions of the anti-obesity drug orlistat (XenicalTM) in breast cancer cells: blockade of cell cycle progression, promotion of apoptotic cell death and PEA3-mediated transcriptional repression of Her2/neu (erbB-2) oncogene.
Menendez JA; Vellon L; Lupu R
Ann Oncol; 2005 Aug; 16(8):1253-67. PubMed ID: 15870086
[TBL] [Abstract][Full Text] [Related]
18. Methylation-dependent regulation of hypoxia inducible factor-1 alpha gene expression by the transcription factor Kaiso.
Pierre CC; Longo J; Bassey-Archibong BI; Hallett RM; Milosavljevic S; Beatty L; Hassell JA; Daniel JM
Biochim Biophys Acta; 2015 Dec; 1849(12):1432-41. PubMed ID: 26514431
[TBL] [Abstract][Full Text] [Related]
19. The N-terminal transactivation domain of the glucocorticoid receptor mediates apoptosis of human small cell lung cancer cells.
Singh N; Taylor K; Mjoli PB; Poolman T; Ray DW; Sommer P
Genes Chromosomes Cancer; 2014 Dec; 53(12):999-1007. PubMed ID: 25116573
[TBL] [Abstract][Full Text] [Related]
20. Kaiso protects human umbilical vein endothelial cells against apoptosis by differentially regulating the expression of B-cell CLL/lymphoma 2 family members.
Xue X; Zhang J; Lan H; Xu Y; Wang H
Sci Rep; 2017 Aug; 7(1):7116. PubMed ID: 28769046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
